Founded in 2013 by mathematicians from the University of Cambridge and government cyber intelligence experts in the US and the UK, Darktrace is recognized today as the world’s leading AI company for cyber security.
With deep expertise in mathematics and machine learning, as well as operational experience defending critical national assets, our founding team started Darktrace to empower organizations to defend their systems against the most sophisticated cyber-threats.
Darktrace’s pioneering technology, the Enterprise Immune System, applies AI to the cyber defense challenge for the first time, and has proven itself successful in detecting cyber-threats that existing, legacy systems cannot.
It quickly became clear that the technology was powerful enough to identify a diverse range of threats at their earliest stages – including insider attacks, latent vulnerabilities, cloud-based threats and even state-sponsored espionage.
In 2016, Darktrace’s leadership in AI was reinforced with the launch of the first-ever autonomous response technology, Darktrace Antigena. This innovation allowed the Enterprise Immune System to react to in-progress cyber-attacks in a highly precise way, giving security teams the time they desperately need to catch up. When WannaCry ransomware attacks hit hundreds of organizations in 2017, Darktrace Antigena reacted in seconds, protecting customer networks from the inestimable damage.
In November 2017, the company announced a new business unit, Darktrace Industrial, dedicated to fighting threats in industrial and SCADA networks, building on a strong base of customers that use Darktrace AI to protect critical national infrastructure and operational technology.
Darktrace is headquartered in San Francisco and Cambridge, UK, with 40 offices globally and over 800 employees. It is privately owned, with investors including KKR, Summit Partners, Vitruvian Partners, Samsung Ventures, TenEleven Ventures, Hoxton Ventures, Talis Capital, Invoke Capital and Insight Venture Partners.